Matteo Bonotti, PhD, is Lecturer in Political Theory in the School of Politics, International Studies and Philosophy at Queen’s University Belfast. He received his MSc in International and European Politics and his PhD in Politics from the University of Edinburgh. His research interests lie in contemporary political theory, with a special focus on issues concerning ethical pluralism and diversity in their various manifestations (e.g. religious, linguistic, dietary) and how the state should respond to them.
Michele Loi, PhD, has a postdoctoral research grant funded by FCT (Portuguese Foundation for Science and Technology) at the University of Minho in Braga, Portugal. He received his PhD in political theory from Libera Università Internazionale degli Studi Sociali (LUISS) in Rome. His main contributions to political philosophy and bioethics relate to the debate on human enhancement and the ethical relevance of genetics and epigenetics.
Richard Stith, JD, PhD, is Senior Research Professor at Valparaiso University Law School in Indiana and also a member of the Academic Council for the doctoral program in law at the Universidad de los Andes in Chile. He received both his law degree and a doctorate in ethics from Yale University. From Harvard and from the University of California, Berkeley, he holds degrees in political theory. He has taught and published on comparative law and legal philosophy both domestically and internationally, including Germany, Spain, India, China, Ukraine, Chile, and Mexico.
Kirstin Borgerson, PhD, is an Associate Professor of Philosophy at Dalhousie University in Canada. Dr. Borgerson researches and teaches in medical epistemology and medical ethics. Her paper in this issue came out of a CIHR-funded project on “The Ethics of Evidence: Social Value and Clinical Trial Design” in which she investigated whether medical researchers have an ethical obligation to adjust their methods or questions in order to conduct research on matters of greatest clinical importance. [End Page vi]